[Drug-induced neuroleptic malignant syndrome]

Nihon Naika Gakkai Zasshi. 2007 Aug 10;96(8):1627-33. doi: 10.2169/naika.96.1627.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antipsychotic Agents / adverse effects*
  • Autonomic Nervous System Diseases / chemically induced
  • Autonomic Nervous System Diseases / diagnosis
  • Dantrolene / therapeutic use
  • Diagnosis, Differential
  • Dopamine Agonists / therapeutic use
  • Electroconvulsive Therapy
  • Fever / chemically induced
  • Fever / diagnosis
  • Humans
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / etiology*
  • Neuroleptic Malignant Syndrome / physiopathology
  • Neuroleptic Malignant Syndrome / therapy
  • Prognosis
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Syndrome

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents
  • Dopamine Agonists
  • Serotonin Uptake Inhibitors
  • Dantrolene